Rectal dose reduction using three-dimensional conformal radiotherapy for locally advanced prostate cancer: A combination of conformal dynamic-arc and five-static field technique

Radiotherapy and Oncology

Volumn 90, Issue 3, 2009, Pages 318-324

  Sasaoka, Masahiro ^a   Nishikawa, Akimasa ^a   Futami, Tomoyuki ^a   Nishida, Kouichi ^a   Miwa, Hiroki ^a   Kadoya, Kyuuichi ^a  

^a Ise Municipal Hospital   (Japan)

Author keywords

3D CRT; Dose escalation; Dose volume histogram; Dynamic arc; Prostate cancer; Rectal toxicity

Indexed keywords

ARTICLE; BLADDER CAPACITY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; FEMUR HEAD; HISTOGRAM; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

HUMANS; MALE; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY, CONFORMAL; RECTUM;

EID: 61349139956     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.10.008     Document Type: Article

References (49)

1. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
2. Kupelian P.A., Buchsbaum J.C., Eishaikh M.A., Reddy C.A., and Klein E.A. Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome. Int J Radiat Oncol Biol Phys 57 (2003) 629-639
3. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
4. Jereczek-Fossa B.A., and Orecchia R. Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer. Radiother Oncol 84 (2007) 197-215
5. Dearnaley D.P., Hall E., Lawewnce D., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 92 (2005) 488-498
6. Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalation-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomized controlled trial. Lancet Oncol 8 (2007) 475-487
7. van Tol-Geerdink J.J., Stalmeier P.F., Pasker-de Jong P.C., et al. Systematic review of the effect of radiation dose on tumor control and morbidity in the treatment of prostate cancer by 3D-CRT. Int J Radiat Oncol Biol Phys 64 (2006) 534-543
8. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 (2005) 1233-1239
9. Storey M.R., Pollack A., Zagars G., Smith L., Antolak J., and Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635-642
10. Kupelian P.S., Reddy C.A., Klein F.A., and Willoughby T.R. Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 51 (2001) 988-993
11. Tucker S.L., Dong L., Cheung R., et al. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 1589-1601
12. Luo C., Yang C.C., Narayan S., et al. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 1253-1262
13. Jereczek-Fossa B.A., Cattani F., D'Onofrio A., et al. Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of two treatment techniques (six coplanar fields and two dynamic arcs). Radiother Oncol 81 (2006) 294-302
14. Jereczek-Fossa B.A., Vavassori A., Fodor C., et al. Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patients. Int J Radiat Oncol Biol Phys 71 (2008) 784-794
15. Perez C.A., Michalski J.M., Purdy J.A., Wasserman T.H., Williams K., and Lockett M.A. Three-dimensional conformal therapy or standard irradiation in localized carcinoma of prostate: preliminary results of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 47 (2000) 629-637
16. van Lin E.N., Hoffmann A.L., van Kollenburg P., Leer J.W., and Visser A.G. Rectal wall sparing effect of three different endorectal balloons in 3D conformal and MRT prostate radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 565-576
17. Zhu S., Mizowaki T., Nagata Y., et al. Comparison of three radiotherapy treatment planning protocols of definitive external-beam radiation for localized prostate cancer. Int J Clin Oncol 10 (2005) 398-404
18. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomized trial. Lancet 353 (1999) 267-272
19. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1116
20. Zelefsky M.J., Fuks Z., Happersett L., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55 (2000) 241-249
21. Vora S.A., Wong W.W., Schild S.E., Ezzell G.A., and Halyard M.Y. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 1053-1058
22. De Meerleer G.O., Fonteyne V.H., Vakaet L., et al. Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control. Radiother Oncol 82 (2007) 160-166
23. International Commission on Radiation Units and Measurements (ICRU). Report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). Bethesda, MD: International Commission on Radiation Units and Measurements: 1999.
24. Hanks G.E., Hanlon A.L., Pinover W.H., Horwitz E.M., Price R.A., and Schultheiss T. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys 46 (2000) 823-832
25. Akazawa P.F., Roach III M., Pickett P., et al. Three dimensional comparison of blocked arcs vs. four and six field conformal treatment of the prostate. Radiother Oncol 41 (1996) 83-88
26. Zagars G.K., von Eschenbach A.C., Johnson D.E., and Oswald M.J. The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 14 (1988) 701-709
27. Vargas C.E., Galalae R., Demanes J., et al. Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic nodes treated with high-dose radiation. Int J Radiat Oncol Biol Phys 63 (2005) 1474-1482
28. Asbell S.O., Martz K.L., Shin K.H., et al. Impact of surgical staging in evaluating the radiotherapeuic outcome in RTOG #77-06, a phase III study for T1BnoMo (A2) and T2NoMo (B) prostate carcinoma. Int J Radiat Oncol Biol Phys 40 (1998) 769-782
29. Lawton C.A., DeSilvio M., Roach III M., et al. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: update analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys 69 (2007) 646-655
30. Ashman J.B., Zelefsky M.J., Hunt M.S., Leibel S.A., and Fuks Z. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 765-771
31. Pollack A. A call for more with a desire for less: pelvic radiotherapy with androgen deprivation in the treatment of prostate cancer. J Clin Oncol 21 (2003) 1899-1901
32. Ennis R.D. Uncertainties regarding pelvic radiotherapy for prostate cancer. J Clin Oncol 22 (2004) 2254-2255
33. Roach III M. In reply [Letter]. J Clin Oncol 22 (2004) 2255-2257
34. Gallagher M.J., Brereton H.D., Rostock R.A., et al. A prospective study of treatment techniques to minimize the volume pf pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 12 (1986) 1565-1573
35. Shu H.K., Lee T.T., Vigneauly E., et al. Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer. Urology 57 (2001) 102-107
36. Roach M., DeSilvio M., Thomas C.R., et al. Progression free survival (PFS) after whole-pelvic (WP) vs. mini-pelvic (MP) or prostate only (PO) radiotherapy (RT): A subset analysis of RTOG 9413, a phase III prospective randomized trial using neoadjuvant and concurrent (N&CHT). Int J Radiat Oncol Biol Phys 60 (2004) S264-S265 [abstract]
37. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18 (2000) 3904-3911
38. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
39. Huang E.H., Pollack A., Levy L., et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1314-1321
40. Fiorino A., Sanguineti G., Cozzarini C., et al. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 953-962
41. Vargas C., Martinez A., Kestin L.L., et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1297-1308
42. Kuban D., Pollack A., Huang E., et al. Hazards of dose escalation in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 1260-1268
43. Fiorino C., Fellin G., Rancati T., et al. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys 70 (2008) 1130-1137
44. van der Laan H.P., van den Bergh A., Schilstra C., Vlasman R., Meertens H., and Langendik J.A. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 1138-1145
45. Valicenti R.K., Winter K., Cox J.D., et al. RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?. Int J Radiat Oncol Biol Phys 57 (2003) 614-620
46. Kopper P.C., Stroom J.C., van Putten W.L., et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys 43 (1999) 727-734
47. Teh B.S., Mai W.Y., Uhl B.M., et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys 49 (2001) 705-712
48. Nuyttens J.J., Milto S., Rust P.f., and Turrisi III A.T. Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer. Radiother Oncol 64 (2002) 209-214
49. Tobler M., Watson G., and Laevitt D.D. The application of dynamic field shaping and dynamic dose rate control in conformal rotational treatment of the prostate. Med Dosim 27 (2002) 251-254